Piramal Enterprises is reportedly targeting to be among the top three players in the $2.2-billion over-the-counter (OTC) pharmaceutical products business in four years. At present, the company is at seventh slot.
With Rs 15,000 crore in cash and investments on the books of Piramal Enterprises, the company has already made six acquisitions for the health care business in the past two years. Three of these were made in the OTC business.
Piramal Enterprises is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 972.55 |
| Shriram Finance | 1015.40 |
| Aditya Birla Capital | 368.90 |
| Chola Invest & Fin. | 1689.15 |
| Tata Capital | 325.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: